Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016

• Main Authors: Carlos Manuel Guerrero-López, Edson Serván-Mori, Roxana Rodríguez-Franco, Julio César Montañez-Hernández, Héctor Gómez-Dantés
• Format: Article
• Language: English
• Published: Instituto Nacional de Salud Pública 2019-06-01
• Series: Salud Pública de México
• Subjects: global burden of disease, méxico, lung cancer, dalys.
• Online Access: http://www.saludpublica.mx/index.php/spm/article/view/9932
• ISSN: 0036-3634

Objective. To show lung cancer (LC) mortality and disability-adjusted life years (DALYs) in Mexico. Materials and methods. With the visualization tools at the Global Burden of Disease Study website, we analyzed LC mortality and disability-adjusted life years (DALYs) by state, sex, socio­demographic index (SDI), age, and risk factors between 1990 and 2016. Results. Mortality rate decreased from 13.9 to 9.1 per 100 000 between 1990 and 2016. This reduction is greater among men. However, deaths by LC rose from 5 478 to 8 470. DALYs rate also decreased. Northern states with higher SDI face a larger burden from LC but exhibited greater reductions compared with southern, less developed states. The burden of LC is concentrated among older population. Smoking is the main risk factor for LC. Conclusions. The burden by LC has decreased but is differential between states. LC threatens financially both the health system and individuals, since an important fraction of the population is not protected.